Sentinel lymph node biopsy for non-melanoma skin cancers

Sentinel lymph node biopsy for non-melanoma skin cancers - SLNB for NMSC

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000024452

Enrollment

100

Registered

2016-10-18

Start date

2013-11-19

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non melanoma skin cancers

Interventions

sentinel lymph node biopsy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The diameter of the primary lesion is more the 3 cm.

Exclusion criteria

Exclusion criteria: The patients who have definite lymph node metastasis or distant metastasis

Design outcomes

Primary

Measure	Time frame
incidence of adverse events, sensitivity, specificity, false positive rate, false negative rate	—

Countries

Japan

Contacts

Public ContactSatoshi Fukushima

Kumamoto university Department of Dermatology and Plastic Surgery

derma.prs.ku@gmail.com096-373-5233

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026